Schedule 13G ownership disclosure

Rigel Pharmaceuticals Inc

Common Stock · CUSIP: 766559702

Event date: 2025-09-30

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Morgan Stanley

    Shares: 116,406 · Class: 0.7%

  • Morgan Stanley Capital Services LLC

    Shares: 71,545 · Class: 0.4%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000895421-25-000532
Form type
SCHEDULE 13G/A
Filer
MORGAN STANLEY
CIK
CIK 895421
Filed
Oct 07, 2025
Reporting period
Sep 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub